{"id":31799,"date":"2014-09-23T10:46:21","date_gmt":"2014-09-23T14:46:21","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=31799"},"modified":"2014-09-23T10:46:21","modified_gmt":"2014-09-23T14:46:21","slug":"abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799","title":{"rendered":"AbbVie Inc (NYSE:ABBV) To Make Several Presentations Proposing New Drugs For Cancer And Tumor Therapies"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 09\/23\/2014 (wallstreetpr) \u2013 <strong>AbbVie Inc (NYSE:ABBV) <\/strong>announced that will be presenting findings from new researches at the annual meeting of the European Society of Medical Oncology. As mentioned in the PR Newswire <a href=\"http:\/\/finance.yahoo.com\/news\/abbvie-present-clinical-study-data-120000773.html\" target=\"_blank\">article<\/a>, the conference will be held from Sept 26 through Sept 30, 2014 in Madrid, Spain.<\/p>\n<p style=\"text-align: justify;\">AbbVie Inc (NYSE:ABBV) has been engaged with several new clinical researches which evaluate likely new medicines and drugs. The company has several drugs lined-up in its oncology department and seeks to present the results of these studies this month.<\/p>\n<p style=\"text-align: justify;\"><strong>Latest Findings<\/strong><\/p>\n<p style=\"text-align: justify;\">Among the various study results AbbVie Inc (NYSE:ABBV) seeks to present is a Phase II study finding. The research evaluates the safety and efficiency of veliparib in combination with two widely-acting chemotherapeutic drugs. Veliparib is essentially a poly polymerase (adenosine diphosphate [ADP]\u2013ribose) inhibitor and the combination therapy aims at treating a particular form of cancer. The study analyses the efficacy of the treatment in patients suffering from non-small cell lung cancer.<\/p>\n<p style=\"text-align: justify;\">Veliparib, or ABT-888 is also being evaluated for multiple other tumor types. PARP, a natural bodily enzyme repairs DNA damages and is sometimes responsible for repairing damaged cancer cells as well. Veliparib seeks to prevent this cancer cells repair so as to assist the efficacy of DNA destroying cancer therapies.<\/p>\n<p style=\"text-align: justify;\"><strong>New Researches<\/strong><\/p>\n<p style=\"text-align: justify;\">AbbVie Inc (NYSE:ABBV) also seeks to make an oral presentation of the results from a Phase I study of drug ABT-414. It is an inhibitor of the epidermal growth factor receptor (anti-EGFR) monoclonal antibody conjugation drug therapy. The treatment targets patients who are newly diagnosed with glioblastoma multiforme (GBM), a kind of brain tumor. GBM is the most commonly found and also the most aggressive form of cancerous primary brain tumor.<\/p>\n<p style=\"text-align: justify;\">Apart from this, the drug maker will be presenting a study named ABT-767, which concerns advance-stage solid tumors. The therapy seeks to treat tumors with BRCA 1 and BRCA 2 mutations, as well as high-level Serous Ovarian or Fallopian Tube and Primary Peritoneal Cancer.<\/p>\n<p style=\"text-align: justify;\">\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 09\/23\/2014 (wallstreetpr) \u2013 AbbVie Inc (NYSE:ABBV) announced that will be presenting findings from new researches at the annual meeting of the European Society [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":21657,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[3643,1593,1592],"stock_ticker":[],"class_list":["post-31799","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-abbvie-inc","tag-abbvie-inc-nyseabbv","tag-nyseabbv","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AbbVie Inc (NYSE:ABBV) To Make Several Presentations Proposing New Drugs For Cancer And Tumor Therapies - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AbbVie Inc (NYSE:ABBV) To Make Several Presentations Proposing New Drugs For Cancer And Tumor Therapies - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 09\/23\/2014 (wallstreetpr) \u2013 AbbVie Inc (NYSE:ABBV) announced that will be presenting findings from new researches at the annual meeting of the European Society [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-09-23T14:46:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/AbbVie-Inc.-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"456\" \/>\n\t<meta property=\"og:image:height\" content=\"190\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fiona Gibson\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fiona Gibson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799\"},\"author\":{\"name\":\"Fiona Gibson\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e5ef7ff4b449e42e0b2e812283dba24e\"},\"headline\":\"AbbVie Inc (NYSE:ABBV) To Make Several Presentations Proposing New Drugs For Cancer And Tumor Therapies\",\"datePublished\":\"2014-09-23T14:46:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799\"},\"wordCount\":343,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/AbbVie-Inc.-1.jpg\",\"keywords\":[\"AbbVie Inc\",\"AbbVie Inc. (NYSE:ABBV)\",\"NYSE:ABBV\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799\",\"name\":\"AbbVie Inc (NYSE:ABBV) To Make Several Presentations Proposing New Drugs For Cancer And Tumor Therapies - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/AbbVie-Inc.-1.jpg\",\"datePublished\":\"2014-09-23T14:46:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/AbbVie-Inc.-1.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/AbbVie-Inc.-1.jpg\",\"width\":456,\"height\":190},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AbbVie Inc (NYSE:ABBV) To Make Several Presentations Proposing New Drugs For Cancer And Tumor Therapies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e5ef7ff4b449e42e0b2e812283dba24e\",\"name\":\"Fiona Gibson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f92ca1ce6ecdb59f7bac42afaacd292b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f92ca1ce6ecdb59f7bac42afaacd292b.jpeg\",\"caption\":\"Fiona Gibson\"},\"description\":\"Fiona is a finance graduate and an expert in analyzing market trends.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\",\"https:\/\/x.com\/@fionahime\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/fiona-gibson\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AbbVie Inc (NYSE:ABBV) To Make Several Presentations Proposing New Drugs For Cancer And Tumor Therapies - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799","og_locale":"en_US","og_type":"article","og_title":"AbbVie Inc (NYSE:ABBV) To Make Several Presentations Proposing New Drugs For Cancer And Tumor Therapies - Wall Street PR","og_description":"Boston, MA 09\/23\/2014 (wallstreetpr) \u2013 AbbVie Inc (NYSE:ABBV) announced that will be presenting findings from new researches at the annual meeting of the European Society [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-09-23T14:46:21+00:00","og_image":[{"width":456,"height":190,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/AbbVie-Inc.-1.jpg","type":"image\/jpeg"}],"author":"Fiona Gibson","twitter_misc":{"Written by":"Fiona Gibson","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799"},"author":{"name":"Fiona Gibson","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e5ef7ff4b449e42e0b2e812283dba24e"},"headline":"AbbVie Inc (NYSE:ABBV) To Make Several Presentations Proposing New Drugs For Cancer And Tumor Therapies","datePublished":"2014-09-23T14:46:21+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799"},"wordCount":343,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/AbbVie-Inc.-1.jpg","keywords":["AbbVie Inc","AbbVie Inc. (NYSE:ABBV)","NYSE:ABBV"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799","url":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799","name":"AbbVie Inc (NYSE:ABBV) To Make Several Presentations Proposing New Drugs For Cancer And Tumor Therapies - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/AbbVie-Inc.-1.jpg","datePublished":"2014-09-23T14:46:21+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/AbbVie-Inc.-1.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/AbbVie-Inc.-1.jpg","width":456,"height":190},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/abbvie-inc-nyseabbv-to-make-several-presentations-proposing-new-drugs-for-cancer-and-tumor-therapies-31799#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"AbbVie Inc (NYSE:ABBV) To Make Several Presentations Proposing New Drugs For Cancer And Tumor Therapies"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e5ef7ff4b449e42e0b2e812283dba24e","name":"Fiona Gibson","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f92ca1ce6ecdb59f7bac42afaacd292b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f92ca1ce6ecdb59f7bac42afaacd292b.jpeg","caption":"Fiona Gibson"},"description":"Fiona is a finance graduate and an expert in analyzing market trends.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr","https:\/\/x.com\/@fionahime"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/fiona-gibson"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/31799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=31799"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/31799\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/21657"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=31799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=31799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=31799"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=31799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}